New hope for hispanic type 2 diabetes patients: pharmacist intervention cuts A1c levels

FHS
October 3, 2023
10:35 am

Researchers examined whether pharmacist-led interventions improved adherence to medications and guideline-concordant care based on changes in hemoglobin A1C (HbA1C) levels and systolic blood pressure among Hispanic type 2 diabetes patients.

Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like a pleasant morning to lift the spirits. A cool breeze

August 10, 2023

Once-Rejected Drug Now FDA Approved for CKD-Related Anemia

The FDA approved vadadustat (Vafseo) for chronic kidney disease (CKD)-related anemia in adults who have been on dialysis for at least 3 months, developer Akebia

March 29, 2024

Pharmalittle: We’re reading about fake studies, AbbVie investing in psychedelics, and more

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.